Skip to Content

MainStay Balanced B MBNBX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 29.58  /  +0.17 %
  • Total Assets 456.4 Mil
  • Adj. Expense Ratio
    2.080%
  • Expense Ratio 2.080%
  • Distribution Fee Level High
  • Share Class Type
  • Category Moderate Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Closed
  • TTM Yield 1.04%
  • Turnover 313%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 10:58 PM GMT+0

Morningstar’s Analysis MBNBX

Will MBNBX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay Balanced B's Average Process and People Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MBNBX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

United States Treasury Notes 5%

6.10 28.2 Mil
Government

United States Treasury Notes 4.625%

4.34 20.0 Mil
Government

iShares Intermediate Govt/Crdt Bd ETF

4.15 19.2 Mil

United States Treasury Notes 4.375%

3.47 16.0 Mil
Government

United States Treasury Notes 4.375%

3.09 14.2 Mil
Government

JPMorgan Chase & Co

2.20 10.1 Mil
Financial Services

iShares Russell 1000 Value ETF

2.15 9.9 Mil

Vanguard Russell 1000 Value ETF

1.94 9.0 Mil

Johnson & Johnson

1.68 7.7 Mil
Healthcare

Merck & Co Inc

1.50 6.9 Mil
Healthcare